Fetuin-A expression in human umbilical vein endothelial cells and amnion cells of patients with gestational diabetes mellitus

Selim Afsar; Ayse Yigit; Ruhsen Ozcaglayan; Ceyda S. Usta; Cagla B. Bulbul; Gulay Turan

doi:10.15537/smj.2022.43.7.20220283

References

1.↵
1. Coustan DR,
2. Dyer AR,
3. Metzger BE.
One-step or 2-step testing for gestational diabetes: which is better? Am J Obstet Gynecol 2021; 225: 634–644.
OpenUrl
2.↵
1. Zanardo V,
2. Tortora D,
3. Sandri A,
4. Severino L,
5. Mesirca P,
6. Straface G.
COVID-19 pandemic: impact on gestational diabetes mellitus prevalence. Diabetes Res Clin Pract 2022; 183: 109149.
OpenUrl
3.↵
1. Mack LR,
2. Tomich PG.
Gestational diabetes: diagnosis, classification, and clinical care. Obstet Gynecol Clin North Am 2017; 44: 207–217.
OpenUrl
4.↵
1. Bourebaba L,
2. Marycz K.
Pathophysiological implication of fetuin-A glycoprotein in the development of metabolic disorders: a concise review. J Clin Med 2019; 8: 2033.
OpenUrl
5.↵
1. Guo VY,
2. Cao B,
3. Cai C,
4. Cheng KK,
5. Cheung BMY.
Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Acta Diabetol 2018; 55: 87–98.
OpenUrl
6.↵
1. Akbas H,
2. Kahraman S,
3. Sak S,
4. Akkafa F.
Minor variant of AHSG gene 767C>G polymorphism may decrease the risk of gestational diabetes mellitus. J Obstet Gynaecol 2020; 40: 303–307.
OpenUrl
7.↵
1. Pan X,
2. Wen SW,
3. Bestman PL,
4. Kaminga AC,
5. Acheampong K,
6. Liu A.
Fetuin-A in metabolic syndrome: a systematic review and meta-analysis. PLoS One 2020; 15: e0229776.
OpenUrl
8.↵
1. Lee S,
2. Norheim F,
3. Gulseth HL,
4. Langleite TM,
5. Kolnes KJ,
6. Tangen DS, et al.
Interaction between plasma fetuin-A and free fatty acids predicts changes in insulin sensitivity in response to long-term exercise. Physiol Rep 2017; 5: e13183.
OpenUrl Abstract/FREE Full Text
9.↵
1. Sági B,
2. Peti A,
3. Lakatos O,
4. Gyimesi T,
5. Sulyok E,
6. Wittmann I, et al.
Pro- and anti-inflammatory factors, vascular stiffness and outcomes in chronic hemodialysis patients. Physiol Int 2020; 107: 256–266.
OpenUrl
10.↵
1. Wang WJ,
2. Zhang L,
3. Zheng T,
4. Zhang GH,
5. Du K,
6. Yang MN, et al.
Fetuin-A and fetal growth in gestational diabetes mellitus. BMJ Open Diabetes Res Care 2020; 8: e000864.
OpenUrl Abstract/FREE Full Text
11.↵
1. Jin C,
2. Lin L,
3. Han N,
4. Zhao Z,
5. Liu Z,
6. Luo S, et al.
Effects of dynamic change in fetuin-A levels from the first to the second trimester on insulin resistance and gestational diabetes mellitus: a nested case-control study. BMJ Open Diabetes Res Care 2020; 8: e000802.
OpenUrl Abstract/FREE Full Text
12.↵
1. Wang CY,
2. Su MT,
3. Cheng HL,
4. Kuo PL,
5. Tsai PY.
Fetuin-A inhibits placental cell growth and ciliogenesis in gestational diabetes mellitus. Int J Mol Sci 2019; 20: 5207.
OpenUrl
13.↵
1. Zbucka-Kretowska M,
2. Kuzmicki M,
3. Telejko B,
4. Goscik J,
5. Ciborowski M,
6. Lipinska D, et al.
First-trimester irisin and fetuin-A concentration in predicting macrosomia. J Matern Fetal Neonatal Med 2019; 32: 2868–2873.
OpenUrl
14.↵
1. Kralisch S,
2. Hoffmann A,
3. Lössner U,
4. Kratzsch J,
5. Blüher M,
6. Stumvoll M, et al.
Regulation of the novel adipokines/hepatokines fetuin A and fetuin B in gestational diabetes mellitus. Metabolism 2017; 68: 88–94.
OpenUrl
15.↵
1. Lu D,
2. Yang M,
3. Yao Y,
4. Xie Y.
A clinical research study on the respective relationships between visfatin and human fetuin A and pregnancy outcomes in gestational diabetes mellitus. Taiwan J Obstet Gynecol 2019; 58: 808–813.
OpenUrl
16.↵
1. McIntyre HD,
2. Catalano P,
3. Zhang C,
4. Desoye G,
5. Mathiesen ER,
6. Damm P.
Gestational diabetes mellitus. Nat Rev Dis Primers 2019; 5: 47.
OpenUrl
17.↵
1. Icer MA,
2. Yıldıran H.
Effects of fetuin-A with diverse functions and multiple mechanisms on human health. Clin Biochem 2021; 88: 1–10.
OpenUrl
18.↵
1. Cai Z,
2. Yang Y,
3. Zhang J.
Hepatokine levels during the first or early second trimester of pregnancy and the subsequent risk of gestational diabetes mellitus: a systematic review and meta-analysis. Biomarkers 2021; 26: 517–531.
OpenUrl
19.↵
1. Naito C,
2. Hashimoto M,
3. Watanabe K,
4. Shirai R,
5. Takahashi Y,
6. Kojima M, et al.
Facilitatory effects of fetuin-A on atherosclerosis. Atherosclerosis 2016; 246: 344–351.
OpenUrl CrossRef PubMed
20.↵
1. Wang WJ,
2. Wang S,
3. Yang MN,
4. Dong Y,
5. He H,
6. Fang F, et al.
Fetuin-A in infants born small- or large-for-gestational-age. Front Endocrinol (Lausanne) 2020; 11: 567955.
OpenUrl
21.↵
1. Lu D,
2. Yang M,
3. Yao Y,
4. Xie Y.
A clinical research study on the respective relationships between visfatin and human fetuin A and pregnancy outcomes in gestational diabetes mellitus. Tiwan J Obstet Gynecol 2019; 58: 808–813.
OpenUrl
22.↵
1. Gomez LM,
2. Anton L,
3. Srinivas SK,
4. Elovitz MA,
5. Parry S.
Effects of increased fetuin-A in human trophoblast cells and associated pregnancy outcomes. Am J Obstet Gynecol 2012; 207: 484.
OpenUrl
23.
1. Sanhal CY,
2. Can Kavcar M,
3. Yucel A,
4. Erkeneklı K,
5. Erkaya S,
6. Uygur D.
Comparison of plasma fetuin A levels in patients with early-onset pre-eclampsia vs late-onset pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2016; 200: 108–112.
OpenUrl CrossRef PubMed
24.↵
1. Can Ibanoglu M,
2. Yasar Sanhal C,
3. Ozgu-Erdinc S,
4. Kara O,
5. Yucel A,
6. Uygur D.
Maternal plasma fetuin-A levels in fetal growth restriction: a case-control study. Int J Reprod Biomed 2019; 17: 487–492.
OpenUrl
25.
1. Araujo Júnior E,
2. Peixoto AB,
3. Zamarian AC,
4. Elito Júnior J,
5. Tonni G. Macrosomia
. Best Pract Res Clin Obstet Gynaecol 2017; 38: 83–96.
OpenUrl
26.
Gestational hypertension and preeclampsia: ACOG practice Bulletin summary, number 222. Obstet Gynecol 2020; 135: 1492–1495.
OpenUrl CrossRef
27.
1. Thompson-Branch A,
2. Havranek T.
Neonatal hypoglycemia. Pediatr Rev 2017; 38: 147–157.
OpenUrl Abstract/FREE Full Text

In this issue

Download PDF

Email Article

Citation Tools

Bookmark this article

Cited By...

No citing articles found.

Google Scholar

More in this TOC Section

Show more Original Article

Keywords

[1] 1.↵
Coustan DR,
Dyer AR,
Metzger BE.
One-step or 2-step testing for gestational diabetes: which is better? Am J Obstet Gynecol 2021; 225: 634–644.
OpenUrl

[2] Coustan DR,

[3] Dyer AR,

[4] Metzger BE.

[5] 2.↵
Zanardo V,
Tortora D,
Sandri A,
Severino L,
Mesirca P,
Straface G.
COVID-19 pandemic: impact on gestational diabetes mellitus prevalence. Diabetes Res Clin Pract 2022; 183: 109149.
OpenUrl

[6] Zanardo V,

[7] Tortora D,

[8] Sandri A,

[9] Severino L,

[10] Mesirca P,

[11] Straface G.

[12] 3.↵
Mack LR,
Tomich PG.
Gestational diabetes: diagnosis, classification, and clinical care. Obstet Gynecol Clin North Am 2017; 44: 207–217.
OpenUrl

[13] Mack LR,

[14] Tomich PG.

[15] 4.↵
Bourebaba L,
Marycz K.
Pathophysiological implication of fetuin-A glycoprotein in the development of metabolic disorders: a concise review. J Clin Med 2019; 8: 2033.
OpenUrl

[16] Bourebaba L,

[17] Marycz K.

[18] 5.↵
Guo VY,
Cao B,
Cai C,
Cheng KK,
Cheung BMY.
Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Acta Diabetol 2018; 55: 87–98.
OpenUrl

[19] Guo VY,

[20] Cao B,

[21] Cai C,

[22] Cheng KK,

[23] Cheung BMY.

[24] 6.↵
Akbas H,
Kahraman S,
Sak S,
Akkafa F.
Minor variant of AHSG gene 767C>G polymorphism may decrease the risk of gestational diabetes mellitus. J Obstet Gynaecol 2020; 40: 303–307.
OpenUrl

[25] Akbas H,

[26] Kahraman S,

[27] Sak S,

[28] Akkafa F.

[29] 7.↵
Pan X,
Wen SW,
Bestman PL,
Kaminga AC,
Acheampong K,
Liu A.
Fetuin-A in metabolic syndrome: a systematic review and meta-analysis. PLoS One 2020; 15: e0229776.
OpenUrl

[30] Pan X,

[31] Wen SW,

[32] Bestman PL,

[33] Kaminga AC,

[34] Acheampong K,

[35] Liu A.

[36] 8.↵
Lee S,
Norheim F,
Gulseth HL,
Langleite TM,
Kolnes KJ,
Tangen DS, et al.
Interaction between plasma fetuin-A and free fatty acids predicts changes in insulin sensitivity in response to long-term exercise. Physiol Rep 2017; 5: e13183.
OpenUrl Abstract/FREE Full Text

[37] Lee S,

[38] Norheim F,

[39] Gulseth HL,

[40] Langleite TM,

[41] Kolnes KJ,

[42] Tangen DS, et al.

[43] 9.↵
Sági B,
Peti A,
Lakatos O,
Gyimesi T,
Sulyok E,
Wittmann I, et al.
Pro- and anti-inflammatory factors, vascular stiffness and outcomes in chronic hemodialysis patients. Physiol Int 2020; 107: 256–266.
OpenUrl

[44] Sági B,

[45] Peti A,

[46] Lakatos O,

[47] Gyimesi T,

[48] Sulyok E,

[49] Wittmann I, et al.

[50] 10.↵
Wang WJ,
Zhang L,
Zheng T,
Zhang GH,
Du K,
Yang MN, et al.
Fetuin-A and fetal growth in gestational diabetes mellitus. BMJ Open Diabetes Res Care 2020; 8: e000864.
OpenUrl Abstract/FREE Full Text

[51] Wang WJ,

[52] Zhang L,

[53] Zheng T,

[54] Zhang GH,

[55] Du K,

[56] Yang MN, et al.

[57] 11.↵
Jin C,
Lin L,
Han N,
Zhao Z,
Liu Z,
Luo S, et al.
Effects of dynamic change in fetuin-A levels from the first to the second trimester on insulin resistance and gestational diabetes mellitus: a nested case-control study. BMJ Open Diabetes Res Care 2020; 8: e000802.
OpenUrl Abstract/FREE Full Text

[58] Jin C,

[59] Lin L,

[60] Han N,

[61] Zhao Z,

[62] Liu Z,

[63] Luo S, et al.

[64] 12.↵
Wang CY,
Su MT,
Cheng HL,
Kuo PL,
Tsai PY.
Fetuin-A inhibits placental cell growth and ciliogenesis in gestational diabetes mellitus. Int J Mol Sci 2019; 20: 5207.
OpenUrl

[65] Wang CY,

[66] Su MT,

[67] Cheng HL,

[68] Kuo PL,

[69] Tsai PY.

[70] 13.↵
Zbucka-Kretowska M,
Kuzmicki M,
Telejko B,
Goscik J,
Ciborowski M,
Lipinska D, et al.
First-trimester irisin and fetuin-A concentration in predicting macrosomia. J Matern Fetal Neonatal Med 2019; 32: 2868–2873.
OpenUrl

[71] Zbucka-Kretowska M,

[72] Kuzmicki M,

[73] Telejko B,

[74] Goscik J,

[75] Ciborowski M,

[76] Lipinska D, et al.

[77] 14.↵
Kralisch S,
Hoffmann A,
Lössner U,
Kratzsch J,
Blüher M,
Stumvoll M, et al.
Regulation of the novel adipokines/hepatokines fetuin A and fetuin B in gestational diabetes mellitus. Metabolism 2017; 68: 88–94.
OpenUrl

[78] Kralisch S,

[79] Hoffmann A,

[80] Lössner U,

[81] Kratzsch J,

[82] Blüher M,

[83] Stumvoll M, et al.

[84] 15.↵
Lu D,
Yang M,
Yao Y,
Xie Y.
A clinical research study on the respective relationships between visfatin and human fetuin A and pregnancy outcomes in gestational diabetes mellitus. Taiwan J Obstet Gynecol 2019; 58: 808–813.
OpenUrl

[85] Lu D,

[86] Yang M,

[87] Yao Y,

[88] Xie Y.

[89] 16.↵
McIntyre HD,
Catalano P,
Zhang C,
Desoye G,
Mathiesen ER,
Damm P.
Gestational diabetes mellitus. Nat Rev Dis Primers 2019; 5: 47.
OpenUrl

[90] McIntyre HD,

[91] Catalano P,

[92] Zhang C,

[93] Desoye G,

[94] Mathiesen ER,

[95] Damm P.

[96] 17.↵
Icer MA,
Yıldıran H.
Effects of fetuin-A with diverse functions and multiple mechanisms on human health. Clin Biochem 2021; 88: 1–10.
OpenUrl

[97] Icer MA,

[98] Yıldıran H.

[99] 18.↵
Cai Z,
Yang Y,
Zhang J.
Hepatokine levels during the first or early second trimester of pregnancy and the subsequent risk of gestational diabetes mellitus: a systematic review and meta-analysis. Biomarkers 2021; 26: 517–531.
OpenUrl

[100] Cai Z,

[101] Yang Y,

[102] Zhang J.

[103] 19.↵
Naito C,
Hashimoto M,
Watanabe K,
Shirai R,
Takahashi Y,
Kojima M, et al.
Facilitatory effects of fetuin-A on atherosclerosis. Atherosclerosis 2016; 246: 344–351.
OpenUrl CrossRef PubMed

[104] Naito C,

[105] Hashimoto M,

[106] Watanabe K,

[107] Shirai R,

[108] Takahashi Y,

[109] Kojima M, et al.

[110] 20.↵
Wang WJ,
Wang S,
Yang MN,
Dong Y,
He H,
Fang F, et al.
Fetuin-A in infants born small- or large-for-gestational-age. Front Endocrinol (Lausanne) 2020; 11: 567955.
OpenUrl

[111] Wang WJ,

[112] Wang S,

[113] Yang MN,

[114] Dong Y,

[115] He H,

[116] Fang F, et al.

[117] 21.↵
Lu D,
Yang M,
Yao Y,
Xie Y.
A clinical research study on the respective relationships between visfatin and human fetuin A and pregnancy outcomes in gestational diabetes mellitus. Tiwan J Obstet Gynecol 2019; 58: 808–813.
OpenUrl

[118] Lu D,

[119] Yang M,

[120] Yao Y,

[121] Xie Y.

[122] 22.↵
Gomez LM,
Anton L,
Srinivas SK,
Elovitz MA,
Parry S.
Effects of increased fetuin-A in human trophoblast cells and associated pregnancy outcomes. Am J Obstet Gynecol 2012; 207: 484.
OpenUrl

[123] Gomez LM,

[124] Anton L,

[125] Srinivas SK,

[126] Elovitz MA,

[127] Parry S.

[128] 23.
Sanhal CY,
Can Kavcar M,
Yucel A,
Erkeneklı K,
Erkaya S,
Uygur D.
Comparison of plasma fetuin A levels in patients with early-onset pre-eclampsia vs late-onset pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2016; 200: 108–112.
OpenUrl CrossRef PubMed

[129] Sanhal CY,

[130] Can Kavcar M,

[131] Yucel A,

[132] Erkeneklı K,

[133] Erkaya S,

[134] Uygur D.

[135] 24.↵
Can Ibanoglu M,
Yasar Sanhal C,
Ozgu-Erdinc S,
Kara O,
Yucel A,
Uygur D.
Maternal plasma fetuin-A levels in fetal growth restriction: a case-control study. Int J Reprod Biomed 2019; 17: 487–492.
OpenUrl

[136] Can Ibanoglu M,

[137] Yasar Sanhal C,

[138] Ozgu-Erdinc S,

[139] Kara O,

[140] Yucel A,

[141] Uygur D.

[142] 25.
Araujo Júnior E,
Peixoto AB,
Zamarian AC,
Elito Júnior J,
Tonni G. Macrosomia
. Best Pract Res Clin Obstet Gynaecol 2017; 38: 83–96.
OpenUrl

[143] Araujo Júnior E,

[144] Peixoto AB,

[145] Zamarian AC,

[146] Elito Júnior J,

[147] Tonni G. Macrosomia

[148] 26.
Gestational hypertension and preeclampsia: ACOG practice Bulletin summary, number 222. Obstet Gynecol 2020; 135: 1492–1495.
OpenUrl CrossRef

[149] 27.
Thompson-Branch A,
Havranek T.
Neonatal hypoglycemia. Pediatr Rev 2017; 38: 147–157.
OpenUrl Abstract/FREE Full Text

[150] Thompson-Branch A,

[151] Havranek T.

Main menu

User menu

Search

Fetuin-A expression in human umbilical vein endothelial cells and amnion cells of patients with gestational diabetes mellitus

References

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

CONTENT

JOURNAL

AUTHORS

Main menu

User menu

Search

Fetuin-A expression in human umbilical vein endothelial cells and amnion cells of patients with gestational diabetes mellitus

References

In this issue

Citation Manager Formats

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

CONTENT

JOURNAL

AUTHORS